Cart
sales@molnova.com
Ganoderic acid G
CAS No. 98665-22-6
Ganoderic acid G( —— )
Catalog No. M19843 CAS No. 98665-22-6
Ganoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 221 | In Stock |
|
| 5MG | 169 | In Stock |
|
| 10MG | 268 | In Stock |
|
| 25MG | 451 | In Stock |
|
| 50MG | 646 | In Stock |
|
| 100MG | 919 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGanoderic acid G
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
-
DescriptionGanoderic acid G is a highly oxidized lanostane-type triterpenoid from the fungus ganoderma lucidum.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98665-22-6
-
Formula Weight532.67
-
Molecular FormulaC30H44O8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@H](CC(=O)CC(C)C(O)=O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@@H](O)[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1C[C@@H]3O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ganoderic acid G and I and ganolucidic acid A and B new triterpenoids from Ganoderma lucidum.
molnova catalog
related products
-
2''-O-Galloylhyperin
2''-Galloylhyperin found in Pyrola. It increases ruminal fiber fermentability by formed wall-bound lignin in primary maize cell walls.
-
Moracin M
Moracin M, a phenolic component in the skin of Morus alba Linn., is a potent phosphodiesterase-4 (PDE4) inhibitor with IC50 values of 2.9, 4.5, >40, and >100 μM for PDE4D2, PDE4B2, PDE5A1, and PDE9A2, respectively. Moracin M has anti-inflammatory activity.
-
Epcoritamab
Epcoritamab (GEN3013) is a novel subcutaneous CD3xCD20 bispecific T-cell binding antibody that activates T-cells and directs them to kill malignant CD20(+) B-cells for the study of relapsed or refractory large B-cell lymphoma.
